CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $537.32 | $537K | 44,173 |
| 2026-03-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,091 | $538.41 | $587K | 43,082 |
| 2026-03-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,709 | $539.40 | $922K | 41,373 |
| 2026-03-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −780 | $540.10 | $421K | 40,593 |
| 2026-03-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $540.92 | $43K | 40,513 |
| 2026-03-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 126,000 | ||
| 2026-03-17 | MALCOLM JAN Director | Sale 10b5-1 | −45 | $533.51 | $24K | 125 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $529.16 | $190K | 49,653 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $530.73 | $106K | 49,453 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −564 | $531.69 | $300K | 48,889 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,597 | $532.66 | $851K | 47,292 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,526 | $533.65 | $1.3M | 44,766 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,779 | $534.47 | $951K | 42,987 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,551 | $535.59 | $831K | 41,436 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −763 | $536.49 | $409K | 40,673 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $537.37 | $86K | 40,513 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 135,500 | ||
| 2026-03-16 | Olian Judy D. Director | Sale 10b5-1 | −200 | $535.44 | $107K | 4,445 |
| 2026-03-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −516 | $534.99 | $276K | 8,414 |
Page 146 of 171 · 3,408 trades